Pre-clinical Therapeutics Pipeline Program

This pre-clinical program seeks to accelerate the path of the therapeutic pipeline towards clinical results through the support of ambitious and scientifically robust pre-clinical studies aiming at developing and testing treatments and interventions that can address the unmet needs of people with PD.Parkinson’s disease.

Funding: no fixed limit 

Duration: 2 years

Research Authority due date: 7 days prior to submission 

Full proposal due date: 12.1.23, 23.3.23, 25.5.23, 27.7.23